Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Hypertension

  Free Subscription


15.12.2025

2 Am J Cardiol
2 Am J Hypertens
1 Am J Kidney Dis
1 BMC Neurol
1 Circ Heart Fail
2 Circulation
3 Clin Exp Hypertens
2 Eur Heart J
6 Hypertension
1 J Am Coll Cardiol
5 J Hum Hypertens
1 J Neurosurg
2 JAMA
1 PLoS Med
5 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. KOBAYASHI T, Mahfoud F
    Lessons From Unusual Cases.
    Am J Cardiol. 2025;257:84-87.
    PubMed         Abstract available

  2. KUNKEL KJ, Townsend RR, Kandzari DE
    Renal Denervation: Procedural Aspects and Efficacy.
    Am J Cardiol. 2025;257:7-11.
    PubMed         Abstract available


    Am J Hypertens

  3. PADWAL RS, Dorsch M, Tobe S, Ringrose J, et al
    The Role of Renal Denervation in the Treatment of Hypertension in Canada: A Case-Based Discussion from the Canadian Hypertension Specialists Society.
    Am J Hypertens. 2025 Dec 6:hpaf236. doi: 10.1093.
    PubMed         Abstract available

  4. ZHANG M, Li P, Sheng Y
    Innovative device-based treatments for hypertension.
    Am J Hypertens. 2025 Dec 4:hpaf235. doi: 10.1093.
    PubMed         Abstract available


    Am J Kidney Dis

  5. MALEPATI D, Drawz PE
    Selecting Antihypertensive Medications for Kidney Transplant Recipients: Flying Blind.
    Am J Kidney Dis. 2025 Dec 2:S0272-6386(25)01166.
    PubMed        


    BMC Neurol

  6. NEYAZI A, Neyazi M, Neyazi M, Razaqi N, et al
    Prevalence and types of headache, sleep disturbances and hypertension among non-psychotic patients.
    BMC Neurol. 2025 Dec 9. doi: 10.1186/s12883-025-04579.
    PubMed         Abstract available


    Circ Heart Fail

  7. AGUADO B, Ruffenach G, Lacoste-Palasset T, Gorlach A, et al
    Use of SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors in Pulmonary Hypertension.
    Circ Heart Fail. 2025 Dec 5:e013481. doi: 10.1161/CIRCHEARTFAILURE.125.013481.
    PubMed         Abstract available


    Circulation

  8. CAI A, Bayes-Genis A, Ryan J, Feng Y, et al
    Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial.
    Circulation. 2025 Oct 22. doi: 10.1161/CIRCULATIONAHA.125.076263.
    PubMed         Abstract available

  9. LI F, Poudel B, Andrade-Silva M, Wu J, et al
    Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage.
    Circulation. 2025 Dec 11:10.1161/CIRCULATIONAHA.124.071351.
    PubMed         Abstract available


    Clin Exp Hypertens

  10. LUO R, Huang Y, Leng Y, Liao W, et al
    Blood pressure variability: From predictive marker to intervention target-breaking the vicious cycle of hypertensive target organ damage.
    Clin Exp Hypertens. 2025;47:2601054.
    PubMed         Abstract available

  11. ZHENG J, Lu C
    Metabolic dysfunction-associated fatty liver disease and risk of hypertension in young adults: A cross-sectional study mediated by inflammatory markers.
    Clin Exp Hypertens. 2025;47:2597852.
    PubMed         Abstract available

  12. WEI X, Li L, Zhao G, Luan Y, et al
    Hypertension and Alzheimer's disease: Pathological interplay, comorbidity risks, and new strategies for synergistic management.
    Clin Exp Hypertens. 2025;47:2595154.
    PubMed         Abstract available


    Eur Heart J

  13. BIDEL Z, Nazarzadeh M, Canoy D, McEvoy JW, et al
    Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysis.
    Eur Heart J. 2025 Dec 12:ehaf962. doi: 10.1093.
    PubMed         Abstract available

  14. VERDECCHIA P, Angeli F, Reboldi G
    Should systolic pressure be lowered in isolated diastolic hypertension?
    Eur Heart J. 2025 Dec 12:ehaf950. doi: 10.1093.
    PubMed        


    Hypertension

  15. ZHONG C, Wang M, Liu D, Wei Y, et al
    Antihypertensive Treatments After Acute Ischemic Stroke: to Continue or Not?
    Hypertension. 2025 Dec 5. doi: 10.1161/HYPERTENSIONAHA.125.25575.
    PubMed         Abstract available

  16. ROSSIGNOL P, Clozel M, Dreier RF, Flack JM, et al
    Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension.
    Hypertension. 2025 Dec 9. doi: 10.1161/HYPERTENSIONAHA.125.25563.
    PubMed         Abstract available

  17. SEMENOVYKH K, Pravenec M, Vaneckova I, Houdek P, et al
    Tert Deletion Impairs Circadian Regulation of Blood Pressure in Male Spontaneously Hypertensive Rats.
    Hypertension. 2025 Dec 10. doi: 10.1161/HYPERTENSIONAHA.125.25510.
    PubMed         Abstract available

  18. VUORI M, Ruuskanen MO, Jousilahti P, Salomaa V, et al
    Value of Multiomics Over Clinical Risk Factors in Hypertension Prediction.
    Hypertension. 2025 Dec 11. doi: 10.1161/HYPERTENSIONAHA.125.25358.
    PubMed         Abstract available

  19. RAUSEO E, Salih AM, Cooper J, Abdulkareem M, et al
    Clinical Phenotypes in Hypertension: A Data-Driven Approach to Risk Stratification.
    Hypertension. 2025 Dec 11. doi: 10.1161/HYPERTENSIONAHA.125.25187.
    PubMed         Abstract available

  20. BYRD JB, Batlle D
    Time to Measure Angiotensin II When Screening for Primary Aldosteronism in the Evaluation of Secondary Hypertension.
    Hypertension. 2025 Dec 11. doi: 10.1161/HYPERTENSIONAHA.125.25990.
    PubMed        


    J Am Coll Cardiol

  21. DODSON JA, Adhikari S, Schoenthaler AM, Shimbo D, et al
    Behavioral Economics and Medication Adherence for Hypertension: A Randomized Clinical Trial.
    J Am Coll Cardiol. 2025 Nov 18:S0735-1097(25)10073.
    PubMed         Abstract available


    J Hum Hypertens

  22. OUYANG D, Cao W, Shen Y, Chen L, et al
    Trends and risk factors of hypertension in US Children and Adolescents, 1999-2023.
    J Hum Hypertens. 2025 Dec 5. doi: 10.1038/s41371-025-01102.
    PubMed         Abstract available

  23. DUUS CL, Nielsen SF, Lyksholm TZ, Mose FH, et al
    Sodium reduction is the key ingredient in dietary treatment of hypertension - a randomized controlled trial on sodium, potassium and nitrate.
    J Hum Hypertens. 2025 Dec 4. doi: 10.1038/s41371-025-01104.
    PubMed         Abstract available

  24. SUKSIRIWORABOOT T, Yacharad A, Kositanurit W, Vorasettakarnkij Y, et al
    Prevalence of apparent treatment-resistant hypertension and screening rates for primary aldosteronism in an asian ambulatory care setting.
    J Hum Hypertens. 2025 Dec 4. doi: 10.1038/s41371-025-01105.
    PubMed         Abstract available

  25. ERNST ME, Sheets KM, Webb KL, Fravel MA, et al
    Late-life, visit-to-visit blood pressure variability and its association with sex-specific long-term cognitive outcomes.
    J Hum Hypertens. 2025;39:831-840.
    PubMed         Abstract available

  26. ZACHWYC J, Sharman JE, Kosowski W, Woznicka AK, et al
    Exaggerated blood pressure response to submaximal exercise and cardiac target organ damage: importance of fitness.
    J Hum Hypertens. 2025;39:849-858.
    PubMed         Abstract available


    J Neurosurg

  27. PROKOP K, Opechowska A, Sawicki K, Zarzecki M, et al
    Beyond idiopathic intracranial hypertension: optic nerve decompression for vision preservation in cerebrospinal fluid flow disorders. A mechanism-based approach.
    J Neurosurg. 2025 Dec 5:1-11. doi: 10.3171/2025.8.JNS251211.
    PubMed         Abstract available


    JAMA

  28. PANT S
    Chronic Pain Linked to Hypertension.
    JAMA. 2025 Dec 12. doi: 10.1001/jama.2025.20022.
    PubMed        

  29. ANDERER S
    Hypertension Among Children Has Increased Significantly.
    JAMA. 2025 Dec 5. doi: 10.1001/jama.2025.20012.
    PubMed        


    PLoS Med

  30. WANG LT, Chien WC, Ma KS, Chung CH, et al
    Association of hydralazine use with risk of hematologic neoplasms in patients with hypertension: A nationwide population-based cohort study in Taiwan.
    PLoS Med. 2025;22:e1004646.
    PubMed         Abstract available


    PLoS One

  31. BHANDARI S, Pokharel PK, Maharjan A, Rajbanshi M, et al
    Prehypertension and its associated factors among government employees in Tilottama Municipality of Rupandehi District, Nepal.
    PLoS One. 2025;20:e0338625.
    PubMed         Abstract available

  32. SHARIF AB, Chowdhury SSA, Hossain MZ, Hossain MA, et al
    Prevalence and factors associated with adverse birth outcomes among women with chronic hypertension in Rangpur: A multi-center cross-sectional study.
    PLoS One. 2025;20:e0337526.
    PubMed         Abstract available

  33. OSTERLIND J, Birnefeld J, Birnefeld E, Hultin M, et al
    Study protocol: MRI-based assessment of cerebral blood flow under pharmacologically elevated blood pressure in patients under general anesthesia, and in sedated ICU patients with aneurysmal subarachnoid hemorrhage.
    PLoS One. 2025;20:e0338688.
    PubMed         Abstract available

  34. PITTMAN MC, Perez AD, Tanni KA, Sanderson KR, et al
    Dosing trajectories of antihypertensive agents among preterm neonates: A retrospective, cross-sectional analysis.
    PLoS One. 2025;20:e0336994.
    PubMed         Abstract available

  35. ZHENG C, Liu Y, Zeng S, Xie S, et al
    Association between average triglyceride glucose-body mass index and risk of hypertension in middle-aged and elderly Chinese: A study based on Chinese CHARLS cohort data.
    PLoS One. 2025;20:e0337710.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.